Literature DB >> 19433701

Effect of exposure to small pharmaceutical promotional items on treatment preferences.

David Grande1, Dominick L Frosch, Andrew W Perkins, Barbara E Kahn.   

Abstract

BACKGROUND: Policy discussions concerning pharmaceutical promotion often assume that small promotional items are unlikely to influence prescribing behavior. Our experiment measures whether exposure to these items results in more favorable attitudes toward marketed products and whether policies that restrict pharmaceutical marketing mitigate this effect.
METHODS: This is a randomized controlled experiment of 352 third- and fourth-year medical students at two US medical schools with differing policies toward pharmaceutical marketing. Participants assigned to treatment were exposed to small branded promotional items for Lipitor (atorvastatin) without knowledge that the exposure was part of the study. We measured differences in implicit (ie, unconscious) attitudes toward Lipitor and Zocor (simvastatin) in exposed and control groups with the Implicit Association Test (IAT). Self-reported attitudes were also measured, and a follow-up survey was administered measuring attitudes toward marketing.
RESULTS: Fourth-year students at the University of Miami Miller School of Medicine exposed to Lipitor promotional items had more favorable implicit attitudes about that brand-name drug compared to the control group (IAT effect: 0.66 vs 0.47; P = .05), while the effect was reversed at the University of Pennsylvania School of Medicine (IAT effect: 0.22 vs 0.52; P = .002) where restrictive policies are in place limiting pharmaceutical marketing (interaction effect: P = .003). No significant effect was observed among third-year students. On a "skepticism" scale, University of Miami students held more favorable attitudes toward pharmaceutical marketing compared to University of Pennsylvania students (0.55 vs 0.42; P < .001) but the results were similar to those of a previously published national study (0.42 vs 0.43; P = .53).
CONCLUSIONS: Subtle exposure to small pharmaceutical promotional items influences implicit attitudes toward marketed products among medical students. We observed a reversal of this effect in the setting of restrictive policies and more negative school-level attitudes toward marketing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433701     DOI: 10.1001/archinternmed.2009.64

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

1.  Norwegian medical students' attitudes towards the pharmaceutical industry.

Authors:  Dordi Lea; Olav Spigset; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

2.  A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.

Authors:  Klaus Lieb; Simone Brandtönies
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

3.  Pharmacists' Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-Making.

Authors:  Aaron M Tejani; Peter Loewen; Richard Bachand; Curtis K Harder
Journal:  Can J Hosp Pharm       Date:  2015 Sep-Oct

4.  Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.

Authors:  Klaus Lieb; Cora Koch
Journal:  Dtsch Arztebl Int       Date:  2013-09-02       Impact factor: 5.594

Review 5.  Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review.

Authors:  Mohamed Abbas; Daniela Pires; Alexandra Peters; Chantal M Morel; Samia Hurst; Alison Holmes; Hiroki Saito; Benedetta Allegranzi; Jean-Christophe Lucet; Walter Zingg; Stephan Harbarth; Didier Pittet
Journal:  Intensive Care Med       Date:  2018-09-11       Impact factor: 17.440

6.  White paper: statement on conflicts of interest.

Authors:  Julian Bion; Massimo Antonelli; LLuis Blanch; J Randall Curtis; Christiane Druml; Bin Du; Flavia R Machado; Charles Gomersall; Christiane Hartog; Mitchell Levy; John Myburgh; Gordon Rubenfeld; Charles Sprung
Journal:  Intensive Care Med       Date:  2018-09-06       Impact factor: 17.440

7.  Opioid Prescribing: How Well Do We Know Ourselves?

Authors:  Rachel S Wightman; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-08-04

8.  How quickly do physicians adopt new drugs? The case of second-generation antipsychotics.

Authors:  Haiden A Huskamp; A James O'Malley; Marcela Horvitz-Lennon; Anna Levine Taub; Ernst R Berndt; Julie M Donohue
Journal:  Psychiatr Serv       Date:  2013-04-01       Impact factor: 3.084

9.  Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients?

Authors:  Ross MacKenzie; Wendy Rogers
Journal:  Public Health Ethics       Date:  2015-04-20       Impact factor: 1.940

10.  Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Authors:  Wei-Hsuan Lo-Ciganic; Walid F Gellad; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Ruoxin Zhang; Bobby L Jones; Hasan Guclu; Seth Richards-Shubik; Julie M Donohue
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.